Ahead of IPO, Rubicon Research presents solid fundamentals in a competitive pharmaceutical market marred by Trump tariffs ...

PTC Industries has rallied 25% in the last one month; the Aatmanirbhar Bharat initiative, coupled with increased budgetary allocations and higher indigenisation targets bodes well for the company.

A key expense for most retirees threatens to gobble up some or all of their Social Security "raise" in the upcoming year.